Insider Trades62 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sell | RARE | Howard Horn | Chief Financial Officer | 4,698 | $33.13 | $2.9B | -26.60% | +60.09% | $155.6K | -4.45% | — | Stalk |
| Jun 15, 2026 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 1,899 | $24.62 | $2.9B | -26.60% | +60.09% | $46.8K | -1.97% | — | Stalk |
| Jun 1, 2026 | Sell | RARE | Howard Horn | Chief Financial Officer | 4,653 | $23.77 | $2.9B | -26.60% | +60.09% | $110.6K | -4.22% | — | Stalk |
| May 5, 2026 | Sell | RARE | Eric Crombez | EVP and Chief Medical Officer | 344 | $24.96 | $2.9B | -26.60% | +60.09% | $8.6K | -0.31% | — | Stalk |
| May 1, 2026 | Sell | RARE | Howard Horn | Chief Financial Officer | 4,683 | $24.90 | $2.9B | -26.60% | +60.09% | $116.6K | -4.07% | — | Stalk |
| Apr 1, 2026 | Sell | RARE | Howard Horn | Chief Financial Officer | 4,683 | $20.97 | $2.9B | -26.60% | +60.09% | $98.2K | -5.51% | — | Stalk |
| Mar 6, 2026 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 9,526 | $21.87 | $2.9B | -26.60% | +60.09% | $208.3K | -6.49% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | Dennis Karl Huang | — | 999 | $23.39 | $2.9B | -26.60% | +60.09% | $23.4K | -0.79% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 1,780 | $22.85 | $2.9B | -26.60% | +60.09% | $40.7K | -1.77% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | Eric Crombez | EVP and Chief Medical Officer | 7,029 | $22.80 | $2.9B | -26.60% | +60.09% | $160.3K | -8.44% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 8,135 | $22.80 | $2.9B | -26.60% | +60.09% | $185.5K | -9.63% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | Howard Horn | Chief Financial Officer | 10,044 | $22.65 | $2.9B | -26.60% | +60.09% | $227.5K | -3.70% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | John Richard Pinion | — | 10,029 | $22.80 | $2.9B | -26.60% | +60.09% | $228.7K | -8.35% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | Erik Harris | EVP & Chief Commercial Officer | 10,539 | $22.80 | $2.9B | -26.60% | +60.09% | $240.3K | -10.53% | — | Stalk |
| Mar 2, 2026 | Sell | RARE | Emil D Kakkis | President & CEO | 54,404 | $22.80 | $2.9B | -26.60% | +60.09% | $1.2M | -7.63% | — | Stalk |
| Feb 2, 2026 | Sell | RARE | Howard Horn | Chief Financial Officer | 3,061 | $23.56 | $2.9B | -26.60% | +60.09% | $72.1K | -3.33% | — | Stalk |
| Jan 2, 2026 | Sell | RARE | Howard Horn | Chief Financial Officer | 3,150 | $22.84 | $2.9B | -26.60% | +60.09% | $71.9K | -3.31% | — | Stalk |
| Dec 29, 2025 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 85 | $34.38 | $2.9B | -26.60% | +60.09% | $2.9K | -0.17% | — | Stalk |
| Dec 10, 2025 | Sell | RARE | Howard Horn | Chief Financial Officer | 3,081 | $36.38 | $2.9B | -26.60% | +60.09% | $112.1K | -3.14% | — | Stalk |
| Oct 13, 2025 | Sell | RARE | Howard Horn | Chief Financial Officer | 7,942 | $31.51 | $2.9B | -26.60% | +60.09% | $250.3K | -7.48% | — | Stalk |
| Sep 18, 2025 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 64 | $29.17 | $2.9B | -26.60% | +60.09% | $1.9K | -0.13% | — | Stalk |
| Sep 12, 2025 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 2,450 | $31.17 | $2.9B | -26.60% | +60.09% | $76.4K | -3.24% | — | Stalk |
| Sep 5, 2025 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 84 | $31.39 | $2.9B | -26.60% | +60.09% | $2.6K | -0.17% | — | Stalk |
| Apr 21, 2025 | Sell | RARE | Eric Crombez | EVP and Chief Medical Officer | 762 | $37.93 | $2.9B | -26.60% | +60.09% | $28.9K | -0.53% | — | Stalk |
| Mar 6, 2025 | Sell | RARE | Howard Horn | Chief Financial Officer | 1,785 | $40.40 | $2.9B | -26.60% | +60.09% | $72.1K | -1.65% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 1,108 | $42.20 | $2.9B | -26.60% | +60.09% | $46.8K | -1.03% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | Dennis Karl Huang | — | 1,348 | $42.92 | $2.9B | -26.60% | +60.09% | $57.9K | -0.95% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | Thomas Richard Kassberg | CBO & EVP | 6,536 | $42.16 | $2.9B | -26.60% | +60.09% | $275.6K | -1.22% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | Eric Crombez | EVP and Chief Medical Officer | 8,945 | $42.10 | $2.9B | -26.60% | +60.09% | $376.6K | -8.05% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 12,846 | $42.10 | $2.9B | -26.60% | +60.09% | $540.8K | -14.58% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | John Richard Pinion | — | 14,470 | $42.10 | $2.9B | -26.60% | +60.09% | $609.2K | -5.64% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | Erik Harris | EVP & Chief Commercial Officer | 15,103 | $42.10 | $2.9B | -26.60% | +60.09% | $635.8K | -11.34% | — | Stalk |
| Mar 3, 2025 | Sell | RARE | Emil D Kakkis | President & CEO | 98,434 | $42.20 | $2.9B | -26.60% | +60.09% | $4.2M | -3.31% | — | Stalk |
| Feb 27, 2025 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 2,990 | $42.88 | $2.9B | -26.60% | +60.09% | $128.2K | -2.14% | — | Stalk |
| Dec 30, 2024 | Sell | RARE | Emil D Kakkis | President & CEO | 11,727 | $42.23 | $2.9B | -26.60% | +60.09% | $495.2K | -0.53% | — | Stalk |
| Dec 10, 2024 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 648 | $49.09 | $2.9B | -26.60% | +60.09% | $31.8K | -1.53% | — | Stalk |
| Dec 9, 2024 | Sell | RARE | Emil D Kakkis | President & CEO | 28,273 | $14.63 | $2.9B | -26.60% | +60.09% | $413.6K | -0.64% | — | Stalk |
| Oct 10, 2024 | Sell | RARE | Howard Horn | Chief Financial Officer | 7,465 | $52.76 | $2.9B | -26.60% | +60.09% | $393.9K | -7.48% | — | Stalk |
| Sep 3, 2024 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 91 | $56.19 | $2.9B | -26.60% | +60.09% | $5.1K | -0.22% | — | Stalk |
| Sep 3, 2024 | Sell | RARE | Emil D Kakkis | President & CEO | 20,000 | $55.85 | $2.9B | -26.60% | +60.09% | $1.1M | -0.89% | — | Stalk |
| Aug 6, 2024 | Sell | RARE | Emil D Kakkis | President & CEO | 20,000 | $50.17 | $2.9B | -26.60% | +60.09% | $1.0M | -0.88% | — | Stalk |
| Jun 12, 2024 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 9,806 | $45.00 | $2.9B | -26.60% | +60.09% | $441.3K | -14.47% | — | Stalk |
| May 2, 2024 | Sell | RARE | Eric Crombez | EVP and Chief Medical Officer | 354 | $43.66 | $2.9B | -26.60% | +60.09% | $15.5K | -0.73% | — | Stalk |
| Apr 18, 2024 | Sell | RARE | Eric Crombez | EVP and Chief Medical Officer | 142 | $44.10 | $2.9B | -26.60% | +60.09% | $6.3K | -0.29% | — | Stalk |
| Apr 16, 2024 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 14 | $42.31 | $2.9B | -26.60% | +60.09% | $592.34 | -0.03% | — | Stalk |
| Mar 11, 2024 | Sell | RARE | Thomas Richard Kassberg | CBO & EVP | 11,509 | $49.93 | $2.9B | -26.60% | +60.09% | $574.6K | -4.35% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 462 | $53.74 | $2.9B | -26.60% | +60.09% | $24.8K | -0.49% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | Dennis Karl Huang | — | 470 | $53.69 | $2.9B | -26.60% | +60.09% | $25.2K | -0.41% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | Eric Crombez | EVP and Chief Medical Officer | 1,238 | $53.76 | $2.9B | -26.60% | +60.09% | $66.6K | -1.43% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | Thomas Richard Kassberg | CBO & EVP | 1,285 | $53.75 | $2.9B | -26.60% | +60.09% | $69.1K | -0.23% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | 3,756 | $53.76 | $2.9B | -26.60% | +60.09% | $201.9K | -3.66% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | John Richard Pinion | — | 4,233 | $53.76 | $2.9B | -26.60% | +60.09% | $227.6K | -1.94% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | Erik Harris | EVP & Chief Commercial Officer | 4,768 | $53.76 | $2.9B | -26.60% | +60.09% | $256.3K | -4.49% | — | Stalk |
| Mar 1, 2024 | Sell | RARE | Emil D Kakkis | President & CEO | 17,417 | $53.69 | $2.9B | -26.60% | +60.09% | $935.1K | -2.69% | — | Stalk |
| Feb 7, 2024 | Sell | RARE | Emil D Kakkis | President & CEO | 30,000 | $45.00 | $2.9B | -26.60% | +60.09% | $1.4M | -5.27% | — | Stalk |
| Jan 2, 2024 | Buy | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 3,000 | $21.00 | $2.9B | -26.60% | +60.09% | $63.0K | +12.05% | — | Stalk |
| Dec 29, 2023 | Sell | RARE | Emil D Kakkis | President & CEO | 30,000 | $47.87 | $2.9B | -26.60% | +60.09% | $1.4M | -5.00% | — | Stalk |
| Oct 23, 2023 | Sell | RARE | Thomas Richard Kassberg | CBO & EVP | 79,756 | $19.82 | $2.9B | -26.60% | +60.09% | $1.6M | +0.00% | — | Stalk |
| Oct 19, 2023 | Sell | RARE | Emil D Kakkis | President & CEO | 95,706 | $20.19 | $2.9B | -26.60% | +60.09% | $1.9M | +0.00% | — | Stalk |
| Sep 7, 2023 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 4,163 | $31.29 | $2.9B | -26.60% | +60.09% | $130.2K | -0.21% | — | Stalk |
| Sep 5, 2023 | Sell | RARE | Erik Harris | EVP & Chief Commercial Officer | 6,000 | $37.96 | $2.9B | -26.60% | +60.09% | $227.8K | -10.47% | — | Stalk |
| Sep 1, 2023 | Sell | RARE | Theodore Alan Huizenga | SVP, Chief Accounting Officer | 970 | $37.15 | $2.9B | -26.60% | +60.09% | $36.0K | -2.00% | — | Stalk |